Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Elekta AB (publ)
  6. Company
    EKTA B   SE0000163628

ELEKTA AB (PUBL)

(EKTA B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Elekta AB (publ)
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Sales per Business
20192020Delta
Solutions8 394.0061.9%8 846.0060.6% +5.38%
Service5 161.0038.1%5 755.0039.4% +11.51%
SEK in Million
Sales per region
2020
United States3 571.0024.5%
Europe, Middle East and Africa2 585.0017.7%
China1 833.0012.6%
Asia Pacific1 208.008.3%
Japan813.005.6%
Germany661.004.5%
North and South America611.004.2%
United Kingdom592.004.1%
Italy553.003.8%
Spain424.002.9%
Australia361.002.5%
India357.002.4%
Netherlands346.002.4%
France330.002.3%
Canada300.002.1%
Sweden56.000.4%
SEK in Million
Managers
Name Title Age Since
Gustaf Salford President & Chief Executive Officer 43 2020
John Adebńck Chief Financial Officer & Group Treasurer 56 2020
Steven Wort Chief Operating Officer 57 2017
Caroline Mofors Chief Compliance & Integrity Office, Senior VP 48 2018
Jane M. Birgitta G÷ransson Independent Director 63 2005
Jan Joel Aron Secher Independent Director 63 2010
Wolfgang Reim, Dr. Independent Director 64 2011
Johan Malmquist Independent Director 59 2015
Caroline Leksell Cooke Independent Director 39 2017
Cecilia Ketels Head-Investor Relations - -
Members of the board
Name Title Age Since
Laurent Leksell Chairman 68 2013
Jane M. Birgitta G÷ransson Independent Director 63 2005
Jan Joel Aron Secher Independent Director 63 2010
Wolfgang Reim, Dr. Independent Director 64 2011
Johan Malmquist Independent Director 59 2015
Caroline Leksell Cooke Independent Director 39 2017
Cecilia Wikstr÷m Director 55 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 10 14,250,000 0 0.0% 0 0.0% 93.8%
Stock B 1 368,587,640 359,188,547 97.4% 1,485,289 0.4%
Shareholders
NameEquities%
Fjńrde AP-fonden 25,929,006 7.03%
AMF Fonder AB 19,812,573 5.38%
Swedbank Robur Fonder AB 19,005,560 5.16%
Nordea Investment Management AB 15,489,619 4.20%
T. Rowe Price Associates, Inc. (Investment Management) 14,579,488 3.96%
Handelsbanken Fonder AB 13,568,866 3.68%
SEB Investment Management AB 12,860,457 3.49%
Baillie Gifford & Co. 8,869,287 2.41%
The Vanguard Group, Inc. 8,849,041 2.40%
William Blair Investment Management LLC 8,611,944 2.34%
Holdings
NameEquities%Valuation
ELEKTA AB (PUBL) (EKTA B) 1,485,289 0.40% 21,852,493 USD
Company contact information
Elekta AB
Kungstensgatan 18
Stockholm, Sodermanland 103 93

Phone : +46.8.587.254.00
Fax : +46.8.587.255.00
Web : http://www.elekta.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Elekta AB (publ)
Sector Other Advanced Medical Equipment & Technology